The Zhitong Finance App learned that on Friday, Bright Minds Biosciences (DRUG.US) opened sharply, surging 52 times in 5 trading days, to a record high. As of press time, it had risen more than 165 percent to $57.72. According to the news, the company announced today that it will conduct private equity financing for non-brokered common shares at a price of $21.70 per share (“share issuance”). In addition to shares issued under a stock offering, the company reserves the right to issue each PFW (“PFW offering”) at $21.699 per PFW (“PFW offering”) for each pre-funded corporate warrant (PFWs), together with the share offering. The total gross proceeds from the stock issuance and the PFW offering amounted to $35 million. The company may decide for itself how many PFWs to issue under PFW issuance and how many shares to be issued based on stock issuance.

The Zhitong Finance App learned that on Friday, Bright Minds Biosciences (DRUG.US) opened sharply, surging 52 times in 5 trading days, to a record high. As of press time, it had risen more than 165 percent to $57.72. According to the news, the company announced today that it will conduct private equity financing for non-brokered common shares at a price of $21.70 per share (“share issuance”). In addition to shares issued under a stock offering, the company reserves the right to issue each PFW (“PFW offering”) at $21.699 per PFW (“PFW offering”) for each pre-funded corporate warrant (PFWs), together with the share offering. The total gross proceeds from the stock issuance and the PFW offering amounted to $35 million. The company may decide for itself how many PFWs to issue under PFW issuance and how many shares to be issued based on stock issuance.